Chances are if you are in infected with #COVID19 & have mild symptoms, you will be asked to isolate at home. You are not turning breathless but running a mild fever. You freak out. What next? And enrol for a private hospital's home care package. Here is what follows - Thread -
During the course of reporting this story, we found a patient paying close to Rs 40K for home care package, drugs, diagnostic tests, more tests, CT scans while not developing any complications. But here's what beat every thing. A single set of blood test cost Rs 20k!
We found a wide range of prices at which leading hospitals are offering homecare from Max to Medanta, Fortis and Apollo, the range of costs is as wide as between Rs 4500 to over Rs 21000 (but lab tests and drugs cost additionally of course) Graphic by @ShirtShanks
Delhi is seeing an incredible surge in cases and government's home monitoring services are falling woefully short. One in Two #COVID19 +ve persons will not receive even the first triaging call. State has outsourced it's home calls to Dabur backed HCAH for Rs 2.5 crore for 3 mnths
In today's [free] story for the @TheKenWeb we have unpacked the homecare protagonists in India's #COVID19 care - private hospitals, digital health companies charging sky-high prices to state governments for making phone calls, and patients stuck in middle the-ken.com/story/covid-ho…
While digging deeper into the state - private company collaborations for homecare, we stumbled upon companies like HCAH, CallHealth & Portea got together to share a slice of Karnataka pie, backed by Swasth - a telemedicine alliance of start ups, we earlier wrote about first
And while we were at it, we also discovered a volunteer-led model in @Projectstepone which operates in collaboration with 16 states to provide triaging services in states like Delhi, Karnataka where they do the 1st call to #COVID patient and home monitoring in Mumbai, Bihar etc.
#Thread on clinical trials of #Itolizumab - 20 patients received the drug, another 10 patients (three died) received supportive care, four doses were given, 32 patients were randomized, two patients discontinued. says Dr Sandeep Athalye @Bioconlimited
Predominantly male participation with comorbidities like diabetes, thyroid and blood pressure issues. All 20 patients who were given the drug died. In the arm which did not receive the drug, 3 patients died and 2 needed invasive ventilation before they died. #Itolizumab
Key markers for inflammation IL 6 aand TNF alpha came down in those who received the drug. Serum Ferritin levels also came down. Even D Dimer markers which indicate clotting or coagulopathy #Itolizumab
@ICMRDELHI must make the validation protocol of rapid antibody testing kits in light of these kits being deemed 'faulty,' after import of nearly five lakh at close to Rs 26 crore. Read what this means for centre/states here - thehindubusinessline.com/news/analysis-…@businessline#Thread
Everything that @ICMRDELHI did wrong while going in for the Chinese kits. It had been raising purchase orders since April 3, but no company would supply. Read how procurements were delayed in this story on April 15 - thehindubusinessline.com/news/national/…@businessline
On April 16, @ICMRDELHI said that the kits had arrived from China. 5 lakh of them. From Guangzhou Wondfo Biotech, Zhuhai Livzon Diagnostics. Another 1.5 lakh from a company in Shenzhen were on their way - thehindubusinessline.com/news/rapid-ant…@businessline
So went on in #Covid_19india press briefing yesterday -In the light of sharp spike of cases of novel coronavirus (COVID19), @ICMRDELHI to release mathematical estimations of the best and the worst possible scenarios @businessline@srinivasanravi
which could play out over the next few months as far as the number of new cases are concerned. By Sunday evening, India had recorded 360 confirmed cases of COVID19, of which 24 recovered, 7 died. Spike of 124 cases as compared to the previous day.
According to academic estimate modelings, India could stare at cases running into few lakhs and few thousands of deaths. #Covid19India#Covid19India
First COVID-19 death in #India - Thread - Death of a 76 year old male from Karnataka is confirmed by @MoHFW_INDIA to be caused due to co-morbidity and has also tested positive for COVID-19. @businessline@srinivasanravi @RichaMishraBL
The details of the case are as follows:
He visited Saudi Arabia from 29th January 2020 to 29th February 2020. He was a known case of Hypertension and Asthma. He reached back to Hyderabad on 29th February and went to Kalaburgi.
Among those injured are two professors, Ameet Parmeshwar and Sucharita Sen #JnuViolence
Aishi is JNUSU president who got a two inch deep wound on the head, Nikhil Mathew is another student who was hit with a hammer on the arm and has broken his arm, received fractures. Some students were hit on the legs. Nature of injuries are head injuries and limb fractures.
Absolute chaos outside #AIIMSTraumaCentre the hospital has been surrounded by goons. They are disrupting peace and heckling security that is guarding the gates where #JnuViolence patients are being treated.